About Qualitek Labs Limited
Data last updated:
Qualitek Labs Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Tic Services Private Limited. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 17 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L74999DL2018PLC334105. Its GSTIN is 27AAACQ5400B1Z2 (Maharashtra). The company holds 5 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on BSE: 544091.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹11.65 Cr. It is led by directors including Antaryami Nayak (Managing Director) and Kamal Grover (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 73 National Park, Lajpat Nagar – IV, New Delhi, Delhi, India – 110024.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹124.52 Cr, a growth of 77.3% compared to the previous year. For the same year it recorded a net profit of ₹14.65 Cr (net margin 11.8%) and EBITDA of ₹29.29 Cr (EBITDA margin 23.5%). The net worth stands at ₹152.42 Cr (up 75.6% YoY). Total assets are valued at ₹247.61 Cr (up 71.9% YoY).
The company has about 137 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Qualitek Labs. As per MCA filings, the company has open charges of ₹162.28 Cr and satisfied charges of ₹10.41 Cr on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 2 deals on record (1 rights issue, 1 ipo); the latest was in January 2024. The company has 4 MSME Form 1 returns on record between 2022 and 2023, listing 236 overdue payments to 95 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website qualiteklab.com.
Company details
CIN history
Qualitek Labs has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74999DL2018PLC334105, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74999DL2018PLC334105 | Current |
| U74999DL2018PTC334105 | Previous |
| U74999DL2018PLC334105 | Previous |
Contact details
Qualitek Labs Limited's registered office is in New Delhi, Delhi.
- Registered Address73 National Park, Lajpat Nagar – IV, New Delhi, Delhi, India – 110024
- IndustryTravel and Hospitality, Consumer Professional Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Qualitek Labs operates one associated brand: Qualitek Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Food testing services are provided to ensure safety and quality. | qualiteklab.com |
Business activity
The main business activity of Qualitek Labs is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Qualitek Labs Limited, buy the company report.
Financials of Qualitek Labs Limited
FY 2025-26 filings availableQualitek Labs Limited reported revenue of ₹124.52 Cr (up 77.3% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 125 | 70.23 | 12.01 | 6.35 |
| Revenue growth | +77.3% | - | +89.1% | - |
| EBITDA | 29.29 | 16.38 | 1.26 | 0.72 |
| EBITDA margin | +23.5% | +23.3% | +10.5% | +11.3% |
| Profit before tax | 18.32 | 10.43 | 0.48 | 0.38 |
| Net profit | 14.65 | 6.30 | 0.42 | 0.15 |
| Net profit margin | +11.8% | +9.0% | +3.5% | +2.4% |
| EPS (₹) | 13.38 | 6.31 | 9.17 | 156.10 |
| Balance sheet | ||||
| Total assets | 248 | 144 | 18.26 | 10.70 |
| Net worth | 152 | 86.81 | 0.88 | (0.53) |
| Total debt | 93.64 | 50.30 | 17.35 | 11.22 |
| Cash & bank | 6.05 | 5.17 | 1.03 | 0.14 |
| Net working capital | 36.01 | 29.45 | 3.97 | (1.10) |
| Cash flow | ||||
| Cash from operations | 13.87 | 10.50 | (5.15) | 1.35 |
| Cash from investing | (49.74) | (60.17) | (1.77) | (6.06) |
| Cash from financing | 37.11 | 53.57 | 6.80 | 4.82 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 67.62 | 45.86 | 29.18 | 19.14 | 11.97 | 6.35 |
| Revenue growth | +47.5% | +57.2% | +52.5% | +59.9% | +88.5% | - |
| EBITDA | 16.52 | 11.71 | 8.07 | 5.28 | 2.32 | 1.03 |
| EBITDA margin | +24.4% | +25.5% | +27.7% | +27.6% | +19.4% | +16.2% |
| Profit before tax | 9.60 | 7.10 | 5.82 | 3.95 | 1.55 | 0.69 |
| Net profit | 7.99 | 5.28 | 4.30 | 2.98 | 1.14 | 0.46 |
| Net profit margin | +11.8% | +11.5% | +14.7% | +15.6% | +9.5% | +7.2% |
| EPS (₹) | 7.30 | 5.29 | 5.84 | 5.44 | 24.69 | 461.10 |
| Balance sheet | ||||||
| Total assets | 212 | 115 | 44.92 | 33.41 | 19.22 | 11.00 |
| Net worth | 146 | 85.79 | 32.45 | 9.90 | 1.90 | (0.23) |
| Total debt | 65.60 | 28.51 | 12.25 | 23.45 | 17.29 | 11.22 |
| Cash & bank | 2.14 | 1.72 | 1.77 | 0.35 | 1.02 | 0.13 |
| Net working capital | 14.42 | 8.63 | 6.91 | 3.02 | 5.02 | (0.80) |
| Cash flow | ||||||
| Cash from operations | 7.15 | 8.01 | 5.54 | 7.22 | (5.12) | 1.35 |
| Cash from investing | (38.72) | (67.49) | (11.61) | (17.41) | (1.73) | (6.07) |
| Cash from financing | 31.89 | 60.77 | 6.14 | 10.51 | 6.74 | 4.82 |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Revenue | 125 | 70.23 | 12.01 | 6.35 |
| Revenue growth | +77.3% | - | +89.1% | - |
| Other income | 0.53 | 0.52 | 0.05 | 0.02 |
| Total expenses | 95.23 | 53.85 | 10.75 | 5.63 |
| Employee cost | 0.00 | 24.13 | 3.96 | 1.37 |
| EBITDA | 29.29 | 16.38 | 1.26 | 0.72 |
| EBITDA margin | +23.5% | +23.3% | +10.5% | +11.3% |
| Depreciation | 6.69 | 4.25 | 0.51 | 0.35 |
| Interest | 4.81 | 2.22 | 0.32 | 0.01 |
| Profit before tax | 18.32 | 10.43 | 0.48 | 0.38 |
| Tax | 3.72 | 2.74 | 0.06 | 0.23 |
| Net profit | 14.65 | 6.30 | 0.42 | 0.15 |
| Net profit margin | +11.8% | +9.0% | +3.5% | +2.4% |
| EPS (₹) | 13.38 | 6.31 | 9.17 | 156.10 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Equity & liabilities | ||||
| Share capital | 11.65 | 9.98 | 0.46 | 0.01 |
| Reserves & surplus | 141 | 76.83 | 0.42 | (0.54) |
| Shareholders' funds (net worth) | 152 | 86.81 | 0.88 | (0.53) |
| Minority interest | 0.00 | 5.98 | 0.00 | 0.00 |
| Secured loans | 86.50 | 45.42 | 17.35 | 11.22 |
| Unsecured loans | 7.14 | 4.88 | 0.00 | 0.00 |
| Total debt | 93.64 | 50.30 | 17.35 | 11.22 |
| Total liabilities | 248 | 144 | 18.26 | 10.70 |
| Assets | ||||
| Gross block | 175 | 110 | 8.74 | 6.97 |
| Net block | 152 | 92.08 | 7.60 | 6.34 |
| Capital work in progress | 45.72 | 15.91 | 4.47 | 4.47 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 3.18 | 2.65 | 0.00 | 0.00 |
| Sundry debtors | 42.14 | 28.86 | 2.20 | 1.20 |
| Cash & bank balances | 6.05 | 5.17 | 1.03 | 0.14 |
| Loans & advances | 7.38 | 5.93 | 3.46 | 1.19 |
| Total current assets | 58.75 | 42.61 | 6.69 | 2.53 |
| Total current liabilities | 22.74 | 13.16 | 2.72 | 3.63 |
| Net working capital | 36.01 | 29.45 | 3.97 | (1.10) |
| Total assets | 248 | 144 | 18.26 | 10.70 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Opening cash | 4.31 | 0.41 | 0.14 | 0.03 |
| Net cash from operating activities | 13.87 | 10.50 | (5.15) | 1.35 |
| Net cash from investing activities | (49.74) | (60.17) | (1.77) | (6.06) |
| Net cash from financing activities | 37.11 | 53.57 | 6.80 | 4.82 |
| Net change in cash | 1.24 | 3.90 | (0.12) | 0.11 |
| Closing cash | 5.55 | 5.17 | 1.03 | 0.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Growth | ||||
| Sales growth | +77.3% | - | +89.1% | - |
| EBITDA growth | +78.8% | - | +75.0% | - |
| PBT growth | +75.7% | +2072.9% | +26.3% | +9997.0% |
| Net income growth | +132.5% | - | +180.0% | - |
| Revenue CAGR (3Y) | +169.7% | - | - | - |
| EBITDA CAGR (3Y) | +243.9% | - | - | - |
| Profitability & leverage | ||||
| Net income margin | +11.7% | +11.0% | +3.5% | +2.4% |
| Return on capital employed | - | +9.2% | +5.4% | +3.5% |
| Return on net worth | - | +8.9% | +82.6% | +1027.4% |
| Debt / equity | - | 0.58 | 81.61 | 0.00 |
| Long-term debt / equity | - | 0.32 | 1.28 | 0.00 |
| Interest cover | 21.28 | 18.30 | 42.67 | 2.70 |
| Efficiency & per share | ||||
| Fixed asset turnover | - | 0.64 | 1.53 | 0.91 |
| Inventory turnover | - | 26.50 | 0.00 | 0.00 |
| Debtors turnover | - | 2.43 | 7.06 | 5.29 |
| EPS (₹) | 13.38 | 6.31 | 9.17 | 156.10 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 86.98 | 19.07 | (534.60) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 67.62 | 45.86 | 29.18 | 19.14 | 11.97 | 6.35 |
| Revenue growth | +47.5% | +57.2% | +52.5% | +59.9% | +88.5% | - |
| Other income | 0.24 | 0.15 | 0.08 | 0.21 | 0.05 | 0.02 |
| Total expenses | 51.10 | 34.15 | 21.11 | 13.86 | 9.65 | 5.32 |
| Employee cost | 0.00 | 14.03 | 6.05 | 3.66 | 3.36 | 1.28 |
| EBITDA | 16.52 | 11.71 | 8.07 | 5.28 | 2.32 | 1.03 |
| EBITDA margin | +24.4% | +25.5% | +27.7% | +27.6% | +19.4% | +16.2% |
| Depreciation | 4.63 | 3.27 | 1.40 | 0.84 | 0.50 | 0.35 |
| Interest | 2.53 | 1.49 | 0.93 | 0.70 | 0.32 | 0.01 |
| Profit before tax | 9.60 | 7.10 | 5.82 | 3.95 | 1.55 | 0.69 |
| Tax | 1.64 | 1.82 | 1.52 | 0.99 | 0.41 | 0.23 |
| Net profit | 7.99 | 5.28 | 4.30 | 2.98 | 1.14 | 0.46 |
| Net profit margin | +11.8% | +11.5% | +14.7% | +15.6% | +9.5% | +7.2% |
| EPS (₹) | 7.30 | 5.29 | 5.84 | 5.44 | 24.69 | 461.10 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 11.65 | 9.98 | 7.37 | 5.41 | 0.46 | 0.01 |
| Reserves & surplus | 134 | 75.81 | 25.08 | 4.49 | 1.44 | (0.24) |
| Shareholders' funds (net worth) | 146 | 85.79 | 32.45 | 9.90 | 1.90 | (0.23) |
| Secured loans | 65.40 | 28.31 | 11.95 | 11.70 | 9.09 | 3.28 |
| Unsecured loans | 0.20 | 0.20 | 0.30 | 11.75 | 8.20 | 7.94 |
| Total debt | 65.60 | 28.51 | 12.25 | 23.45 | 17.29 | 11.22 |
| Total liabilities | 212 | 115 | 44.92 | 33.41 | 19.22 | 11.00 |
| Assets | ||||||
| Gross block | 63.40 | 47.29 | 32.88 | 15.64 | 8.70 | 6.97 |
| Net block | 52.31 | 40.65 | 29.51 | 13.66 | 7.57 | 6.34 |
| Capital work in progress | 41.92 | 13.38 | 7.61 | 14.85 | 4.47 | 4.47 |
| Investments | 89.99 | 37.99 | 0.00 | 0.00 | 0.01 | 0.01 |
| Inventories | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 19.70 | 11.79 | 7.85 | 5.83 | 2.19 | 1.20 |
| Cash & bank balances | 2.14 | 1.72 | 1.77 | 0.35 | 1.02 | 0.13 |
| Loans & advances | 4.14 | 2.57 | 2.09 | 2.42 | 4.41 | 1.46 |
| Total current assets | 26.34 | 16.08 | 11.71 | 8.60 | 7.62 | 2.79 |
| Total current liabilities | 11.92 | 7.45 | 4.80 | 5.58 | 2.60 | 3.59 |
| Net working capital | 14.42 | 8.63 | 6.91 | 3.02 | 5.02 | (0.80) |
| Total assets | 212 | 115 | 44.92 | 33.41 | 19.22 | 11.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 1.70 | 0.41 | 0.35 | 0.02 | 0.13 | 0.03 |
| Net cash from operating activities | 7.15 | 8.01 | 5.54 | 7.22 | (5.12) | 1.35 |
| Net cash from investing activities | (38.72) | (67.49) | (11.61) | (17.41) | (1.73) | (6.07) |
| Net cash from financing activities | 31.89 | 60.77 | 6.14 | 10.51 | 6.74 | 4.82 |
| Net change in cash | 0.32 | 1.29 | 0.06 | 0.33 | (0.11) | 0.10 |
| Closing cash | 2.14 | 1.72 | 1.77 | 0.35 | 1.02 | 0.13 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +47.5% | +57.2% | +52.5% | +59.9% | +88.5% | - |
| EBITDA growth | +41.1% | +45.1% | +52.8% | +127.6% | +125.2% | - |
| PBT growth | +35.2% | +22.0% | +47.3% | +154.8% | +124.6% | +9997.0% |
| Net income growth | +51.3% | +22.8% | +44.3% | +161.4% | +147.8% | - |
| Revenue CAGR (3Y) | +52.3% | +56.5% | +66.3% | - | - | - |
| EBITDA CAGR (3Y) | +46.3% | +71.5% | +98.6% | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +11.8% | +11.5% | +14.7% | +15.5% | +9.5% | +7.2% |
| Return on capital employed | - | +10.8% | +17.3% | +17.8% | +12.3% | +6.2% |
| Return on net worth | - | +8.9% | +20.4% | +50.5% | +119.4% | +4600.0% |
| Debt / equity | - | 0.34 | 0.84 | 3.46 | 17.07 | 0.00 |
| Long-term debt / equity | - | 0.25 | 0.48 | 0.89 | 0.27 | 0.00 |
| Interest cover | 21.28 | 17.65 | 13.94 | 15.77 | 17.58 | 1.47 |
| Efficiency & per share | ||||||
| Fixed asset turnover | - | 1.14 | 1.20 | 1.57 | 1.53 | 0.91 |
| Inventory turnover | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | - | 4.67 | 4.27 | 4.77 | 7.06 | 5.29 |
| EPS (₹) | 7.30 | 5.29 | 5.84 | 5.44 | 24.69 | 461.10 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 85.97 | 44.02 | 18.30 | 41.22 | (229.60) |
To see the full year-wise statements and ratios of Qualitek Labs Limited, buy the company report.
Board of directors of Qualitek Labs Limited
Qualitek Labs has 8 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alok Kumar Agarwal Also directs: Efreakz Technologies LLP, Asc Insolvency Services LLP, A S C B S R and Company LLP and 5 more | Director | 17 May 2018 | 8 Years 5 Months | Current |
| Kamal Grover | Whole-Time Director | 18 May 2018 | 8 Years 5 Months | Current |
| Antaryami Nayak Also directs: Aal Partners LLP, Interstellar Testing Centre Private Limited, Quality & Testing Infosolution Private Limited and 1 more | Managing Director | 09 Jan 2023 | 3 Years 9 Months | Current |
| Sulabh Jain | Director | 02 May 2023 | 3 Years 5 Months | Current |
| Manish Wahi Also directs: R. P. Multimetals Limited, Jainik Power Cables Limited, Ace Alpha Tech Limited and 1 more | Director | 02 May 2023 | 3 Years 5 Months | Current |
| Shubhangi Agarwal Also directs: Ampl Capital Limited, Agsa and Associates LLP, Shigan Quantum Technologies Limited and 4 more | Director | 02 May 2023 | 3 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Aug 2026 | 101383671 | Others | ₹1.76 Cr | Open | |
| 23 Apr 2026 | 101354430 | Others | ₹43.08 Lakh | Open | |
| 10 Dec 2025 | 101205223 | Hdfc Bank Limited | ₹103.46 Cr | Open | |
| 21 Apr 2025 | 101084044 | Others | ₹4.93 Cr | Open | |
| 29 Mar 2025 | 101090029 | Others | ₹3.7 Lakh | Open |
To see the full charge records of Qualitek Labs Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Qualitek Labs Limited has 2 deals on record (1 rights issue, 1 ipo); the latest was in January 2024.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2024 | IPO | ₹19.64 Cr | Investors: Public Market Investors |
| Oct 2021 | Rights issue | ₹99 Lakh | Investors: Tic Services Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Qualitek Labs Limited has 1 court case on record: 1 filed by Qualitek Labs. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Civil suit | Filed by the company against Three Son Enterprises | Disposed |
To see the full case history of Qualitek Labs Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Qualitek Labs Limited has 4 MSME Form 1 returns on record between 2022 and 2023, listing 236 overdue payments to 95 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 95)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Chem-Tech Laboratories Pvt Ltd | |||
| Interstellar Testing Centre Private Limited | |||
| Spectro Analytical Labs Private Limited | |||
| Young Engg & Calibration Services Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Qualitek Labs Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Qualitek Labs has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACQ5400B1Z2 | Maharashtra | Active | 28 May 2018 |
| 21AAACQ5400B1ZE | Odisha | Active | 17 Feb 2020 |
| 09AAACQ5400B1Z0 | Uttar Pradesh | Active | 15 Sep 2021 |
| 06AAACQ5400B1Z6 | Haryana | Active | 16 Jan 2023 |
To see the full GST registrations and return filing status of Qualitek Labs Limited, buy the company report.
Recent activity
Qualitek Labs Limited has 14 board changes on record since 2018: 9 appointments and 5 cessations. The latest: Ajay Agarwal ceased to be Additional Director on 24 Sep 2025.
22 earlier events are in the company report.
Frequently asked questions
Qualitek Labs is an active public limited company based in New Delhi, Delhi, India. The company works in consumer professional services, within the travel and hospitality industry. It was incorporated on 17 May 2018 (8+ years old) and is registered under CIN L74999DL2018PLC334105. Listed on BSE: 544091.
Qualitek Labs reported revenue of ₹124.52 Cr for FY 2025-26 (up 77.3% YoY) based on consolidated financials.
Qualitek Labs has 8 current directors:
- Antaryami Nayak - Managing Director
- Kamal Grover - Whole-Time Director
- Mangesh Vitthal Bhosale - Whole-Time Director
- Alok Kumar Agarwal - Director
- Sulabh Jain - Director
- Manish Wahi - Director
- Shubhangi Agarwal - Director
- Ajay Agarwal - Director
The latest financial statements of Qualitek Labs on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 September 2026. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Qualitek Labs is 27AAACQ5400B1Z2, registered in Maharashtra. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 21AAACQ5400B1ZE (Odisha), 09AAACQ5400B1Z0 (Uttar Pradesh), 06AAACQ5400B1Z6 (Haryana).
The CIN (Corporate Identification Number) of Qualitek Labs is L74999DL2018PLC334105. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Qualitek Labs is a listed company as per MCA records. Its shares are listed on BSE (code: 544091).
Qualitek Labs has 1 court case on record: 1 filed by the company.
Qualitek Labs was incorporated on 17 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Qualitek Labs has 2 deals on record (1 rights issue, 1 ipo); the latest was in January 2024.
Ajay Agarwal ceased to be Additional Director on 24 Sep 2025. Mangesh Vitthal Bhosale ceased to be Additional Director on 24 Sep 2025. Ajay Agarwal was appointed as Director on 29 Mar 2025. Qualitek Labs has 14 board changes on record in total.